Literature DB >> 3397908

Improving depression severity assessment--I. Reliability, internal validity and sensitivity to change of three observer depression scales.

W Maier1, M Philipp, I Heuser, S Schlegel, R Buller, H Wetzel.   

Abstract

The Hamilton Depression Scale (HAMD) is the most commonly used scale for depression severity assessment and for antidepressant treatment evaluation. Alternative scales have been proposed by Bech and Rafaelsen (BRMS) and by Montgomery and Asberg (MADRS) to try to overcome the shortcomings of HAMD: they are based on different concepts of severity and different scaling procedures. Comparisons with respect to reliability, validity and ability to detect change have been performed using these scales in different samples. The BRMS proved superior. This result makes it necessary to question the usual procedure of testing the efficacy of antidepressants by means of HAMD alone. Problems in defining the severity of depression and in testing the validity of severity scales are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397908     DOI: 10.1016/0022-3956(88)90022-2

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  14 in total

1.  Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression.

Authors:  Isabella Helmreich; Stefanie Wagner; Roland Mergl; Antje-Kathrin Allgaier; Martin Hautzinger; Verena Henkel; Ulrich Hegerl; André Tadić
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09-30       Impact factor: 5.270

2.  Comparison of depressive symptom severity scores in low-income women.

Authors:  Shawn M Kneipp; John A Kairalla; Jeanne Marie R Stacciarini; Deidre Pereira; M David Miller
Journal:  Nurs Res       Date:  2010 Nov-Dec       Impact factor: 2.381

3.  Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.

Authors:  Roger S McIntyre; Jakub Z Konarski; Deborah A Mancini; Kari A Fulton; Sagar V Parikh; Sophie Grigoriadis; Larry A Grupp; David Bakish; Marie-Josee Filteau; Chris Gorman; Charles B Nemeroff; Sidney H Kennedy
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

Review 4.  The interface of clinical psychopharmacology and psychopathology.

Authors:  O Benkert; W Maier
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression.

Authors:  K Knubben; F M Reischies; M Adli; P Schlattmann; M Bauer; F Dimeo
Journal:  Br J Sports Med       Date:  2006-10-24       Impact factor: 13.800

6.  The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures.

Authors:  Thomas J Carmody; A John Rush; Ira Bernstein; Diane Warden; Stephen Brannan; Daniel Burnham; Ada Woo; Madhukar H Trivedi
Journal:  Eur Neuropsychopharmacol       Date:  2006-06-12       Impact factor: 4.600

7.  Assessing dimensional and categorical aspects of depression: validation of the AMDP Depression Scale.

Authors:  E Lauterbach; H-J Rumpf; B Ahrens; H-J Haug; R Schaub; H Schönell; R-D Stieglitz; F Hohagen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

8.  Validity of the definite and semidefinite questionnaire version of the Hamilton Depression Scale, the Hamilton Subscale and the Melancholia Scale. Part I.

Authors:  Jesper Bent-Hansen; Per Bech
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-03-02       Impact factor: 5.270

9.  A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.

Authors:  Charles H Bombardier; Jesse R Fann; Catherine S Wilson; Allen W Heinemann; J Scott Richards; Ann Marie Warren; Larry Brooks; Catherine A Warms; Nancy R Temkin; Denise G Tate
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

Review 10.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.